Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market Size, Share and Forecast 2025 to 2034

Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market Size is valued at USD 392.7 Mn in 2025 and is predicted to reach USD 614.3 Mn by the year 2034 at a 5.1% CAGR during the forecast period for 2025 to 2034.

Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market Size, Share & Trends Analysis Distribution by Type (Single Lumen PICC, Double Lumen PICC, and Triple Lumen PICC), Application (Parenteral Nutrition, Blood Sampling, and Medication Administration), End-user (Hospitals, Neonatal Intensive Care Units (NICUs), and Clinics and Specialty Care Centers), and Segment Forecasts, 2025-2034

A type of catheter known as a neonatal peripherally inserted central venous catheter (PICC) is made especially for use in the newborn intensive care unit (NICU) to deliver intravenous drugs, fluids, and nutrition straight into the central circulation. This catheter is peripherally inserted, which means that it is placed in a peripheral vein (such as the arm or leg) and then moved through the vasculature until the tip reaches a central vein close to the heart, usually the superior vena cava.

By decreasing the need for several peripheral venipunctures and lowering the danger of infection and vascular damage in these susceptible individuals, they offer a safe and effective way to administer drugs and fluids. The neonatal peripherally inserted central venous catheters (PICCs) market is steadily growing due to the increasing prevalence of preterm births and the expanding demand for sophisticated newborn critical care.

In addition, the improvements in catheter technology, such as smaller-diameter catheters made especially for newborns, better biocompatibility materials that reduce the risk of infection, and the increasing use of minimally invasive procedures, are driving the neonatal peripherally inserted central venous catheters (PICCs) market's expansion.

The growing healthcare professionals' understanding of the advantages of PICCs over conventional central venous catheters in neonatal care is contributing to the market's expansion and encouraging broader implementation in neonatal intensive care units (NICUs). However, there may be limitations to the growth of the neonatal peripherally inserted central venous catheters (PICCs) market due to factors such as strict regulatory permissions, the possibility of PICC line installation and administration issues, and the affordability of other treatments.

Since PICCs have a lesser risk of mechanical difficulties than standard central lines, their adoption is also being accelerated by increased healthcare workers' awareness of optimal procedures in infant vascular access. Additionally, the changing neonatal care landscape offers several strategic opportunities for neonatal peripherally inserted central venous catheter (PICCs) market participants.

Moreover, the increased spending on telemedicine and remote patient monitoring is improving neonatal outcomes, lowering readmission rates, and establishing routes for post-discharge PICC maintenance. Bedside insertion is becoming more accurate due to advancements in imaging technology like portable ultrasonography and near-infrared vein visibility, which are increasing adoption in settings with limited resources. Thus, these factors are anticipated to boost the neonatal peripherally inserted central venous catheter (PICC) market expansion over the forecast period.

Competitive Landscape

Which are the Leading Players in Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market?

• Becton, Dickinson and Company (BD)
• Teleflex Incorporated
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• Medical Components, Inc. (MedComp)
• AngioDynamics Inc.
• Cook Medical Inc.
• Argon Medical Devices, Inc.
• ICU Medical, Inc.
• Vygon (UK) Ltd.

Market Dynamics

Growing Number of Preterm Births 

The rising rate of preterm births worldwide is one of the main factors propelling the neonatal peripherally inserted central venous catheter (PICC) market. The World Health Organization reports that newborns, or babies in their first 28 days of life, account for roughly 41% of all under-five child deaths annually. A baby's chance of dying during the first four weeks of life is almost fifteen times higher than that of any other period before one year of life.

Approximately 3.3 million of the 8.2 million under-five child deaths that occur each year take place during the first four weeks of life. Thus, the need for safe and efficient vascular access devices designed specifically for newborns is greatly increased by this growing statistic. Simultaneously, improvements in catheter materials, such as biocompatible polymers and antimicrobial coatings, are improving safety profiles and lowering problems like thrombosis and infections. Additionally, the purchase of cutting-edge catheterization equipment is being fueled by the increase in hospital investments in NICU infrastructure, which is being pushed by both public and private healthcare funding.

Restrain/Challenge

High Expense of Advanced Medical Equipment

The high expense of cutting-edge medical equipment, such as PICC catheters, is one of the major obstacles to the growth of the neonatal peripherally inserted central venous catheter (PICC) market. Budgetary restrictions make it difficult for many healthcare facilities, especially those in low-income areas, to purchase such specialized equipment.

Furthermore, the intricacy of the neonatal peripherally inserted central venous catheter (PICC) insertion procedures calls for qualified specialists, which may be a barrier in less developed regions. Additionally, the possibility of PICC catheter-related problems, such as thrombosis and infection, is another limitation. Some healthcare professionals may decide against using PICC catheters in favor of less complicated alternatives after weighing the advantages against these hazards.

Single Lumen PICC Segment is Expected to Drive the Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market

The single lumen PICC category held the largest share in the neonatal peripherally inserted central venous catheter (PICCs) market in 2024, propelled by improvements in procedural procedures and catheter technology. Echogenic catheters and biocompatible silicone materials are examples of innovations that are greatly enhancing patient safety and clinical results in neonatal care by increasing insertion accuracy and decreasing problems.

Additionally, hospitals and home healthcare settings are adopting smart catheter designs and minimally invasive placement techniques more frequently, which is increasing market demand. Furthermore, post-insertion management is being transformed by the incorporation of digital tracking and telehealth monitoring systems, which are improving patient monitoring and caregiver confidence.

Hospitals Segment is Growing at the Highest Rate in the Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market
In 2024, the hospitals category dominated the neonatal peripherally inserted central venous catheter (PICCs) market because neonatal intensive care units (NICUs), where the majority of critically ill and preterm babies receive specialized medical care, are concentrated in hospital settings.

PICCs are a crucial part of standard newborn treatment since hospitals handle complicated neonatal situations that call for long-term intravenous access for parenteral feeding, antibiotics, and life-sustaining drugs. Additionally, the hospitals are preferred over other treatment settings because they have trained nurses, vascular access teams, and expert neonatologists on hand to assure safe PICC line insertion, monitoring, and maintenance.

Why North America Led the Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market?

The neonatal peripherally inserted central venous catheter (PICCs)s market was dominated by the North America region in 2024 because of its sophisticated healthcare system and significant R&D expenditures devoted to breakthroughs in neonatal care. The region's robust regulatory frameworks and substantial government funding for newborn health initiatives promote consistent market growth.

Additionally, in order to speed up product creation and market penetration, key stakeholders' strategic goals concentrate on cross-sector collaborations and regulatory approvals. While new competitors can benefit from niche inventions and focused regional expansion, incumbents must invest in next-generation catheter technologies and digital integration.

Neonatal Peripherally Inserted Central Venous Catheter (PICCs) Market Report Scope: